Orally Active Fusion Inhibitor of Respiratory Syncytial Virus

BMS-433771 was found to be a potent inhibitor of respiratory syncytial virus (RSV) replication in vitro. It exhibited excellent potency against multiple laboratory and clinical isolates of both group A and B viruses, with an average 50% effective concentration of 20 nM. Mechanism-of-action studies d...

全面介紹

書目詳細資料

發表在:	Antimicrob Agents Chemother
Principais autores:	Cianci, Christopher, Yu, Kuo-Long, Combrink, Keith, Sin, Ny, Pearce, Bradley, Wang, Alan, Civiello, Rita, Voss, Stacey, Luo, Guangxiang, Kadow, Kathy, Genovesi, Eugene V., Venables, Brian, Gulgeze, Hatice, Trehan, Ashok, James, Jennifer, Lamb, Lucinda, Medina, Ivette, Roach, Julia, Yang, Zheng, Zadjura, Lisa, Colonno, Richard, Clark, Junius, Meanwell, Nicholas, Krystal, Mark
格式:	Artigo
語言:	Inglês
出版:	American Society for Microbiology (ASM) 2004
主題:	Antiviral Agents
在線閱讀:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC321540/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/14742189/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.48.2.413-422.2004
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!